SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-028421
Filing Date
2024-02-08
Accepted
2024-02-08 16:44:11
Documents
9
Effectiveness Date
2024-02-08

Document Format Files

Seq Description Document Type Size
1 S-8 d774885ds8.htm S-8 56200
2 EX-5.1 d774885dex51.htm EX-5.1 16807
3 EX-10.2 d774885dex102.htm EX-10.2 144191
4 EX-10.5 d774885dex105.htm EX-10.5 69722
5 EX-23.1 d774885dex231.htm EX-23.1 1518
6 EX-FILING FEES d774885dexfilingfees.htm EX-FILING FEES 32219
7 GRAPHIC g774885g0206120708721.jpg GRAPHIC 2494
8 GRAPHIC g774885g0206120708881.jpg GRAPHIC 3385
9 GRAPHIC g774885g0206120709026.jpg GRAPHIC 3744
  Complete submission text file 0001193125-24-028421.txt   335482
Mailing Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608
Business Address 5980 HORTON STREET SUITE 550 EMERYVILLE CA 94608 5106268331
Kyverna Therapeutics, Inc. (Filer) CIK: 0001994702 (see all company filings)

IRS No.: 831365441 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276952 | Film No.: 24609784
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)